A. Anatomical sites | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lymphoma subtype | Entry into SLO | Entry into extranodal tissues | Retention in tissues | Egress | |||||||
CCR7 | CCL21 | αL | CXCR4 | CXCL12 | α4 | CXCR5 | CXCL13 | S1PR2 | S1PR1 | S1PR3 | |
SLO | ± | +++ | + | ++ | ± | + | ++ | ± | +++ | ± | + |
OAL | ± | + | +++ | +++ | + | +++ | +++ | + | - | ± | ++ |
LL | + | ± | ± | ± | ± | - | +++ | NA | |||
B. Histological features | |||||||||||
Lymphoma subtype | Entry into SLO | Entry into extranodal tissues | Retention in tissues | Egress | |||||||
CCR7 | CCL21 | αL | CXCR4 | CXCL12 | α4 | CXCR5 | CXCL13 | S1PR2 | S1PR1 | S1PR3* | |
FL | ± | +++ | + | + | + | ++ | ++ | + | ± | ± | + |
MZL | ± | +++ | ++ | +++ | + | ++ | ++ | + | - | + | + |
DLBCL | ± | +++ | + | ++ | + | ++ | +++ | + | ++ | - | + |
MCL | ± | +++ | ± | ++ | - | ++ | ++ | + | ± | ++ | + |